A hot topic also for radiopharmaceuticals and nuclear medicine patients: tremendous differences exist in patient access to innovative oncology treatments across European countries. A recent report presents the key delaying factors and strategies how to overcome them.
EANM goes fully virtual on many days this October.
Due to the development of the COVID-19 pandemic, the EANM has taken the decision to postpone all ESMIT events that were supposed to take place in 2020.
As part of a multi-disciplinary consortium, EANM was awarded with a 30-month project by the European Commission on the constant improvement of clinical audits, that started in January 2020.